Immunitybio Inc (IBRX)

$7.04 0.00 (0.00%)

16:00 EDT IBRX Stock Quote Delayed 30 Minutes

IBRX Stock Earnings: ImmunityBio Misses EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 10, 2024

IBRX stock results show that ImmunityBio missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

The 3 Best Bargain Stocks to Buy in May 2024

Even Worse than Gamestop? 3 Meme Stocks That Are Screaming Sells

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Volume:

Previous Close -

Market Cap 2.75B

PE Ratio -6.46

EPS -1.09

Volume (Avg. Vol.) 59,209

Day's Range -

52-Week Range $1.25 - $10.53

Dividend & Yield N/A (N/A)

IBRX Stock Predictions, Articles, and Immunitybio Inc News

From InvestorPlace
From the Web

IBRX Stock Earnings: ImmunityBio Misses EPS, Beats Revenue for Q4 2023

By InvestorPlace Earnings Mar 19, 2024

IBRX stock results show that ImmunityBio missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Feb 26, 2024

We're starting the trading week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!

M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024

By Larry Ramer, InvestorPlace Contributor Jan 2, 2024

Two factors --lower interest rates and the low valuation of many biotech stocks -- are likely to result in many biotech companies being acquired in…

7 Small-Cap Stocks With Massive Growth Potential

By Louis Navellier and the InvestorPlace Research Staff Nov 9, 2023

Small-cap stocks can generate oversized returns, particularly when they hit on a new product or provide a unique service.

3 Biotech Moonshots to Bet on the Future of Health

By Larry Ramer, InvestorPlace Contributor Nov 6, 2023

Thanks to their potential blockbuster drugs, these three biotech stocks may yield huge returns for patent investors willing to take the risk.

3 Very Oversold Biotech Stocks to Buy Right Now

By Larry Ramer, InvestorPlace Contributor Aug 29, 2023

These biotech stocks have tumbled a great deal in recent months, but their long-term outlooks remain quite strong.

Looking for a Bargain? 3 Biotech Stocks to Buy That Are Down 20%-60% in 2023

By Larry Ramer, InvestorPlace Contributor Aug 1, 2023

Since the pharmaceutical sector is very lucrative in America, these biotech stock bargains can be very profitable.

7 High-Risk, High-Reward Stocks to Buy in June

By Larry Ramer, InvestorPlace Contributor Jun 12, 2023

These are the best high-risk, high-reward stocks to buy in June. They can all generate big profits for investors.

Why Is ImmunityBio (IBRX) Stock Down 54% Today?

By William White, InvestorPlace Writer May 11, 2023

ImmunityBio (IBRX) stock is falling on Thursday after the company got a response letter from the FDA concerning its bladder cancer treatment.

The 7 Most Undervalued Growth Stocks for Your May Buy List

By Larry Ramer, InvestorPlace Contributor May 8, 2023

Economic data and a short-covering rally suggest that the outlook for undervalued growth stocks is improving.

3 Stocks to Buy That Could Be the Next Biotech Breakthrough

By Larry Ramer, InvestorPlace Contributor Apr 16, 2023

Biotech stocks are highly speculative, but it's possible to choose ones with excellent risk-reward ratios.

7 Unknown Biotech Stocks That Could Rocket in 2023

By Faisal Humayun, InvestorPlace Contributor Sep 23, 2022

Unknown biotech stocks that are poised for a big rally in 2023. Emerging biotech companies with a promising clinical pipeline.

7 Best Pharmaceutical Stocks to Buy Now

By Muslim Farooque, InvestorPlace Contributor Jul 20, 2022

These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world.

7 Cheap Biotech Stocks to Buy Now

By Muslim Farooque, InvestorPlace Contributor May 19, 2022

These biotech stocks are speculative, but could potentially blow up in the next couple of years with new treatments in the pipelines.

7 Biotech Stocks to Buy With Key Catalysts for April

By Shanthi Rexaline Apr 5, 2022

Biotech stocks are very sensitive to some key catalysts such as the FDA decision date, aka PDUFA date, clinical readouts/presentations and Adcom meeting. The month of April will see some companies belonging to the sector seeing some of these make-or-break catalysts.

Immunitybio Inc (IBRX)

IBRX Stock Earnings: ImmunityBio Misses EPS, Beats Revenue for Q1 2024

The 3 Best Bargain Stocks to Buy in May 2024

Even Worse than Gamestop? 3 Meme Stocks That Are Screaming Sells

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Immunitybio Inc (IBRX)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

IBRX Stock Predictions, Articles, and Immunitybio Inc News

Subscriber Sign in